Experienced and dedicated laboratory professional with over 7 years of diverse experience in various laboratory settings. My passion for laboratory work drives my commitment to excellence and innovation. I have a broad skill set that includes performing advanced analytical techniques, team leading and a strong ability to troubleshoot and solve complex problems. My background spans clinical, research, and industrial settings, allowing me to adapt quickly and effectively to new environments and challenges. I am eager to leverage my expertise to contribute to impactful progress at Select Services.
Teamwork and Communication
Strong Work Ethic
Problem-Solving
Attention to Detail
Punctual and Reliable
Critical Thinking
Inventory and Stocking
Quality Inspection
Analytical Thinking
Acquisition of cabozantinib-sensitive MET D1228N mutation during progression on crizotinib in MET-amplified triple-negative breast cancer. Parsons BM, Meier DR, Richmond CS, Gurda GT, Burkard ME, Deming DA, Kenny PA (2020) Clinical Breast Cancer 20(4):e433-438
Amphiregulin deletion strongly attenuates the development of estrogen receptor-positive tumors in p53 mutant mice. Meier DR, Girtman MA, Lofgren KA, Kenny PA. (2020) Breast Cancer Research & Treatment 179:653-660.
Mutant GATA3 Actively Promotes the Growth of Normal and Malignant Mammary Cells. Emmanuel N, Lofgren KA, Peterson EA, Meier DR, Jung EH, Kenny PA (2018) Anticancer Research (38)4435-4441
Adaptation of an amplicon-based human cancer next-generation sequencing panel assay for murine tumors. Meier DR, Lofgren KA, Gurda GT, Kenny PA (2018) Analytical Biochemistry 551:26-28
Exceptional response to crizotinib in an MET-amplified triple-negative breast tumor. Parsons BM, Meier DR, Gurda GT, Lofgren KA & Kenny PA. Journal of Clincal Oncology - Precision Oncology
Glycogen debranching enzyme (AGL) is a novel regulator of non-small cell lung cancer growth. CS Richmond, D Oldenburg, G Dancik, DR Meier, B Weinhaus, S Guin. Oncotarget 9 (24), 16718
Genomic case report of a low grade bladder tumor metastasis to lung. MJ Van Every, G Dancik, V Paramesh, GT Gurda, DR Meier, SE Cash, S Guin. BMC urology 18, 1-7
Exome sequencing in high breast and ovarian cancer incidence families which lack detectable mutations in established cancer susceptibility genes. PA Kenny, MA Girtman, JA Deviley, DR Meier, C Vos, CS Richmond, CANCER RESEARCH 79 (4)
Baculovirus Fibroblast Growth Factors are Mitogens for Both Insect and Mammalian Cells. C Finnerty, Meier DR. ASM Microbe 2016, Boston MA